Smiths Detection Equips NATO With Vehicle Scanning Technology in Luxembourg
Smiths Detection, a global leader in threat detection and security screening technologies, today announces that it has successfully completed the delivery and installation of a mobile high-energy inspection system trailer, the HCVM XT, at the NATO Support and Procurement Agency (NSPA) in Capellen, Luxembourg.
The NSPA site requires all external construction vehicles, and other equipment providers, to be scanned for potential threats that enter the site such as incendiary and explosive devices, radiological materials, weaponry and unauthorized surveillance or covert equipment.
Smiths Detection’s HCVM XT X-ray screening system quickly and efficiently screens for threats at the NSPA site while meeting the most demanding international security-screening requirements with a minimal size footprint and external infrastructure. The HCVM XT has a throughput of up to 25 vehicles an hour in mobile scanning mode and up to 100 trucks an hour in pass-through mode, with a steel penetration of up to 320mm, providing detailed X-ray images that also distinguishes organic and inorganic material. Smiths Detection is in the process of training NSPA agents to operate the product.
“We are delighted to be given the opportunity to supply the NSPA with this mobile high-energy inspection system and to be extending our work in Luxembourg, following on from our partnership with Luxembourg Customs using the same technology” said Jasper van Gend, Head of Market, Europe North & East. “Against a backdrop of increasingly complex threats, the NSPA is now well equipped to efficiently detect and deal with any potential threats coming onto the site utilising the HCVM XT, with its six scanning modes and adjustable scanning heights and angles.”
When equipped with the optional iCMORE radioactive-material detection system, the HCVM can carry out simultaneous X-ray inspections and an analysis to detect radioactive gamma and neutron materials.
ENDS
About HCVM XT:
https://www.smithsdetection.com/products/hcvm-mobile-x-ray-systems-smiths-detection/
About Smiths Detection:
Smiths Detection is a global leader in threat detection and screening technologies for aviation, ports and borders, urban security and defence. With more than 40 years of field-tested experience, we deliver the solutions needed to protect society from the threat and illegal passage of explosives, prohibited weapons, contraband, toxic chemicals and narcotics.
Our mission is to help make the world a safer place – and do this by using technology to develop innovative solutions and services which protect life, safeguard society and uphold the free flow of trade.
For more information visit http://www.smithsdetection.com.
About NSPA:
NATO Support and Procurement Agency (NSPA) brings together, in a single organization, acquisition, logistic, medical and infrastructural capabilities, operational and systems support and services to the NATO nations, NATO Military Authorities and partner nations.
As NATO's primary enabler, its mission is to provide effective and cost efficient multinational solutions to the Alliance, its 30 Nations and Partners. NSPA is a customer-funded agency, operating on a "no profit - no loss" basis.
As one of the three NATO Agencies, NSPA operates under North Atlantic Council-approved charters. The Agency is the executive body of the NATO Support and Procurement Organisation (NSPO), of which all 30 NATO nations are members. Those nations represented on the NSPO Agency Supervisory Board (ASB), provide strategic direction and guidance to NSPA and oversee its activities and performance.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005075/en/
Contact information
Media Contacts:
FTI Consulting:
Tom Hufton/Georgina Reeves
sc.smithsdetection@fticonsulting.com, +44 (0)20 3727 1000
Smiths Detection:
Sophie Mills, Global Communications Manager
sophie.mills@smithsdetection.com, + 44 (0)73 8423 6474
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MarkLines Gen-AI Beta Version Released for Automotive Industry13.1.2026 02:00:00 EET | Press release
MarkLines Co., Ltd. (Headquarters: Minato-ku, Tokyo; President & CEO: Makoto Sakai; TYO:3901) announced its launch of the "MarkLines Gen-AI Beta Version," the new feature for B2B users in the automotive industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112383839/en/ "MarkLines Gen-AI Beta Version" can take questions in natural language and instantly give highly reliable, relevant data drawn from MarkLines’ extensive automotive database (Image: MarkLines Co., Ltd.) This AI-powered feature enables users to ask questions in natural language and instantly receive highly reliable, relevant data drawn from MarkLines’ extensive automotive database. Moreover, the system analyzes this information by leveraging the rich content across its platform and delivers clear, concise, text-based insights. By combining trusted data with advanced analytical capabilities through generative AI, this service represents a first-of-its-kind
Australian Defence Force Secures Satellite Communications on SES IS-2212.1.2026 23:30:00 EET | Press release
Satellite communications solutions provider SES will provide secure uninterrupted satellite communications to the Australian Defence Force (ADF) for a minimum of 16 years thanks to a new extended agreement. The service will be provided via the SES Intelsat 22 satellite and an ultra-high frequency (UHF) military communications payload. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112137182/en/ Assistant Secretary Space Systems Branch, Michael Hunt, formalizes contract negotiations for the through-life support of the IS-22 satellite with Rory Welch, senior vice-president of service delivery at SES Space and Defense. Photos: Corporal Annika Smit Under the renewed arrangement, SES will reposition the IS-22 satellite to a new orbital slot specified by the ADF, continuing a mission that has been the cornerstone of Australia’s secure military communications since IS-22’s launch in 2012. SES will build a dedicated ground segmen
NetApp Appoints Paul Fipps to the Board of Directors12.1.2026 23:05:00 EET | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced that Paul Fipps, President of Global Customer Operations at ServiceNow, has joined its Board of Directors. The board now has ten directors, nine of whom are independent, and 50% of whom have been appointed within the last five years. Fipps brings more than 20 years of experience driving technology-enabled growth and customer transformation. At ServiceNow, he currently leads global sales, customer success, partner ecosystems, and field operations. He previously served as EVP of Worldwide Sales at ServiceNow and as President of Under Armour Connected Fitness and Chief Experience Officer at Under Armour, overseeing global direct-to-consumer, connected fitness, and digital experiences. He also previously served on the advisory board of Quantum Metric. Fipps holds a B.S. in Information Systems, an MBA from the University of Baltimore, and is a graduate of The Wharton School’s Advanced Management Program. “P
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor12.1.2026 21:00:00 EET | Press release
Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) for pimicotinib as a systemic treatment for patients with tenosynovial giant cell tumor (TGCT). The application is based on the primary results and longer-term follow-up of the global Phase 3 MANEUVER study, which demonstrated deep and durable tumor responses and meaningful improvements in clinical outcomes with pimicotinib. “With pimicotinib, we have an opportunity to significantly advance care for people living with TGCT, a painful and debilitating disease that has few effective and well-tolerated treatment options beyond surgery,” said David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “Based on clinical trial results showing not only a reduction in tumor burden, but also the ability to help alleviate symptoms like pain and stiffness in the global Phase 3 MANEUVER study
Fabentech receives Marketing Authorization for Ricimed®, an antidote against ricin poisoning12.1.2026 20:32:00 EET | Press release
Fabentech, a French biopharmaceutical company specializing in medical countermeasures against biological threats, today announces that it has been granted Marketing Authorization for Ricimed®, a treatment for ricin poisoning. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112241557/en/ Ricimed - Fabentech Ricimed®, an antidote against one of the most toxic natural substances in the world In addition to supportive care, and in severe situations requiring immediate administration, Ricimed® represents a new therapeutic option for the management of acute ricin intoxication. Ricin, among the most dangerous naturally occurring substances, can cause death within hours or days regardless of the route of exposure, making it a major biological threat for many countries. Having demonstrated its ability to specifically target and neutralize ricin before irreversible damage occurs, Ricimed® is an antibody-based therapy relying on poly
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom